Gorman Kevin Charles

US insider· US
Sign in for alerts
  • REDUCEDT+30

    Neurocrine Biosciences Inc · NASDAQ

    −7,839 sh · $1.2M

    Filed 15 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Neurocrine Biosciences Inc · NASDAQ

    +14,343 sh

    Filed 15 Sept 2026SEC Form 4view source